NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said in a filing with the US Securities and Exchange Commission this week that the total consideration for its acquisition of Propel Labs' cell sorting system was $49.6 million. The firm announced the acquisition a couple of weeks ago but had said at the time that the purchase price was undisclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.